Project Details
Description
A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of Prolastin®-C Liquid plus Standard Medical Treatment (SMT) versus SMT alone in Hospitalized Subjects with COVID-19
| Status | Active |
|---|---|
| Effective start/end date | 2/1/21 → 2/28/26 |
Funding
- GRIFOLS THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.